|- candidate number||1770|
|- NTR Number||NTR465|
|- Date ISRCTN created||27-jan-2006|
|- date ISRCTN requested||18-nov-2005|
|- Date Registered NTR||18-okt-2005|
|- Secondary IDs||ZonMw: project id 2200002 |
|- Public Title||The implementation of a Dutch computer-generated tailored smoking cessation program AROM by pharmacists and general practitioners.|
|- Scientific Title||The implementation of a Dutch computer-generated tailored smoking cessation program AROM by pharmacists and general practitioners.|
|- hypothesis||One tailored letter on smoking cessation will lead to more quit attempts at follow-up.|
|- Healt Condition(s) or Problem(s) studied||Smoking cessation|
|- Inclusion criteria||Having smoked in the last 7 days.|
|- Exclusion criteria||Younger than 17 years of age.|
|- mec approval received||yes|
|- multicenter trial||no|
|- Type||2 or more arms, randomized|
|- planned startdate ||1-jan-1999|
|- planned closingdate||31-dec-2005|
|- Target number of participants||1500|
|- Interventions||Adult smokers will recieve either a a tailored letter about smoking cessation (experimental group) or a thank you letter for participating (control group).|
|- Primary outcome||1. Quitting activity between baseline and follow-up; |
2. Abstinence between baseline and follow-up.
|- Secondary outcome||N/A|
|- Trial web site||N/A|
|- status||stopped: trial finished|
|- CONTACT FOR PUBLIC QUERIES||PhD. Hein Vries, de|
|- CONTACT for SCIENTIFIC QUERIES||PhD. Hein Vries, de|
|- Sponsor/Initiator |
(Source(s) of Monetary or Material Support)
|ZON-MW, The Netherlands Organization for Health Research and Development|
|- Publications||1. Hoving EF, Mudde AN, de Vries H. Intention to adopt a smoking cessation expert system within a self-selected sample of Dutch general practitioners. European Journal of Cancer Prevention (in press).|
2. Hoving EF, Mudde AN, de Vries H. Predictors of smoking relapse in a sample of Dutch adult smokers; the roles of gender and action plans. Addictive Behaviors (in press).
|- Brief summary||This project aims to test the efficacy of the implementation of a computerized tailoring approach AROM by community pharmacists and general practitioners (GPs).|
In study 1, 40 community pharmacies will distribute 200 baseline questionnaires about smoking cessation to their smoking patients. Partipating smokers will be randomly assigned to the experimental (E) and control (C) condition. The smokers in te E-group will receive a tailored letter about smoking cessation (generated by AROM).
In study 2, the same procedure will be followed now using general practices as the setting to access smokers; 84 practices will distribute the questionnaires.
In both studies, follow-ups will take place at 3 and 12 months after baseline to measure short and longer term effects on smoking cessation. Process evaluation data, cost effectiveness data as well as data about the rate of adoption by patients will be measured and analysed as well.
|- Main changes (audit trail)|
|- RECORD||18-okt-2005 - 9-okt-2008|